Aspirin in primary prevention: a case for selective use

J Cardiovasc Pharmacol. 2026 Jun 5. doi: 10.1097/FJC.0000000000001841. Online ahead of print.ABSTRACTLow-dose aspirin has a well-established role in secondary prevention of cardiovascular disease but use in primary prevention remains uncommon due to limited evidence of benefit and risk of adverse ef

M Myra Lewontin

The impact of 24-h shift on cardiac anesthesia fellows

Front Public Health. 2026 Jun 10;14:1807234. doi: 10.3389/fpubh.2026.1807234. eCollection 2026.ABSTRACTOBJECTIVE: To investigate the workload, sleep quality, and psychological wellbeing of anesthesiologists at a large volume cardiovascular center.METHODS: Eighteen anesthesiologists were enrolled fro

R Rongli Liu

Association between the C-reactive protein-triglyceride-glucose index and incident cardiovascular disease in middle-aged and older adults with arthritis: a nationwide prospective cohort study with hospital-based cross-sectional replication

Front Immunol. 2026 Jun 10;17:1854928. doi: 10.3389/fimmu.2026.1854928. eCollection 2026.ABSTRACTBACKGROUND: Arthritis encompasses heterogeneous joint and rheumatic conditions and is associated with increased cardiovascular disease (CVD) risk. The C-reactive protein-triglyceride-glucose index (CTI)

F Feng Luo

Differences in clinical features and prognosis between hypertriglyceridemia and other causes of acute pancreatitis: a dual perspective based on metabolic disorders and inflammatory response

Front Endocrinol (Lausanne). 2026 Jun 10;17:1851662. doi: 10.3389/fendo.2026.1851662. eCollection 2026.ABSTRACTBACKGROUND: To investigate the clinical features and prognosis of acute pancreatitis (AP) with different etiologies.METHODS: A total of 242 patients with AP admitted to the First Affiliated

T Tong Wu